Projekt per år
Personlig profil
Biografi
I have an extensive background in experimental studies and physico-chemical characterization of surfaces, interfaces, nanoscale layers and particle materials in close connection to material science, biophysics and nanotechnology. I received my PhD in 1999 from the Department of Physical Chemistry at Åbo Akademi University. After this I worked 10 years at KSV Instruments Ltd/Biolin Scientific Oy, a company providing high-tech, precision analytical instruments for nanoscale study of interfaces. In January 2010 I returned to academia as a senior researcher at University of Helsinki and held an Academy of Finland Research Fellow position between August 2010 - July 2015. In 2018 I obtained a university lecturer position in pharmaceutical technology at University of Helsinki, and since 1.9.2021 I have been appointed as a professor in New Drug Formulations (position shared between University of Helsinki and Åbo Akademi University). I am also a group leader of the Pharmaceutical Biophysics research group at the Faculty of Pharmacy at University of Helsinki and a member of the BioNanoMaterials group at Åbo Akademi University. My main research focus is to utilize model surfaces, living cells, nanoscience and –technology, and various physico-chemical label-free characterization techniques (e.g., surface plasmon resonance, quartz crystal microbalance and time-resolved Raman spectroscopy) and well-established tools in life sciences to improve the mechanistic understanding of drug and nanoparticle action and delivery.
Expertis relaterad till FN:s globala mål för hållbar utveckling (SDG:er)
2015 godkände FN:s medlemsstater 17 globala mål för en hållbar utveckling (SDG:er), för att utrota fattigdomen, skydda planeten och garantera framgång för alla. Denna personens arbete bidrar till följande SDG(:er):
Externa befattningar
Professor, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki
1 sep. 2021 → …
Docent in Pharmaceutical Nanotechnology, Faculty of Pharmacy, University of Helsinki
1 sep. 2020 → …
Fingeravtryck
- 1 Liknande profiler
Samarbeten och ledande forskningsområden under de senaste fem åren
-
NAP4DIVE: Non-Animal Platform for Nanoparticle-Based Delivery Across the Blood-Brain Barrier Interface with Vehicle Evolution
Sahlgren, C. (Ansvarig forskare), Rosenholm, J. (CoPI), Zhang, H. (CoPI), Viitala, T. (CoPI), Lafond, S. (CoPI) & Baghirov, H. (CoI)
01/01/25 → 31/12/28
Projekt: EU
-
MADNESS: Centre of Excellence in Materials-driven solutions for combatting antimicrobial resistance
Rosenholm, J. (Ansvarig forskare), Porres Paltor, I. (CoPI), Bansal, K. (Koordinator), Lafond, S. (CoPI), Uppstu, P. (CoPI), Viitala, T. (CoPI), Wang, X. (CoPI), Wilen, C.-E. (CoPI), Xu, C. (CoPI), Zhang, H. (CoPI), Lu, Z. (CoI), Verma, J. (CoI), Kumar, V. (CoI), Frejborg, F. (CoI), Wang, S. (CoI), Ran, M. (CoI), Ma, X. (CoI), Yang, W. (CoI), Liang, S. (CoI), Zhang, Y. (CoI), Fan, L. (CoI), Chen, Y. (CoI), Wang, L. (CoI), Zhuang, P. (CoI), Rajan Prakash, D. (CoI), Howaili, F. (CoI), Gulshan, R. (CoI), Yadav, D. (CoI), Pathak, C. (CoI), Mustafa, R. (CoI), Rostami, L. (CoI), Jafari Dargahlou, M. (CoI), Nygård, A. (CoI) & Manasut, P. (CoI)
01/01/24 → 31/12/28
Projekt: Stiftelser och fonder
-
Nordic Pharmaceutical Translation and Innovation
Rosenholm, J. (Ansvarig forskare), Viitala, T. (CoPI), Zhang, H. (CoPI), Salo-Ahen, O. (CoPI), Filppula, A. (CoPI), Wang, X. (CoPI), Bansal, K. (CoI), Kulkov, I. (CoI), Ameyaw Ahen, F. (CoI), Salminen, T. A. (CoPI), Airenne, T. (CoI), Lehtonen, J. (CoI), Södergård, B. (CoI) & Rosenberg, S. (CoI)
01/01/24 → 31/12/28
Projekt: Forskning
-
PII: Printed Intelligence Infrastructure
Toivakka, M. (Ansvarig forskare), Xu, C. (CoPI), Bobacka, J. (CoPI), Viitala, T. (CoPI), Rosenholm, J. (CoPI), Österbacka, R. (CoPI), Anttu, N. (CoPI), Huynh, T. P. (CoPI), Peltonen, J. (CoPI), Wang, X. (CoPI), Zhang, H. (CoPI) & Wilen, C.-E. (CoPI)
01/01/24 → 31/12/28
Projekt: Finlands Akademi/Övriga Forskningsråd
-
3D Printing for Personalized Medicine and Customized Drug Delivery
Viitala, T. (Ansvarig forskare), Rosenholm, J. (CoPI) & Xu, C. (CoPI)
01/05/23 → 31/10/25
Projekt: Företag/Business Finland
-
Nanocrystals: Optimization Techniques, Solubility Considerations, and Stability Issues
Junnila, A., Espo, E., Emam, M. F., Namli, I., Myöhänen, E., Karttunen, A.-P., Viitala, T. & Peltonen, L., 2026, Nanocrystal Technologies in Biomedical Sciences: Advances in crystal development, characterization and targeted drug delivery. Mehra, N. K. & Bansal, K. K. (red.). Singapore: Springer, s. 87-126 40 s.Forskningsoutput: Kapitel i bok/konferenshandling › Kapitel › Vetenskaplig › Peer review
-
Novel adenovirus vaccine vectors lacking thrombosis-associated interactions with platelet factor 4
Sallard, E., Pembaur, D., Ciancaglini, M., Manov-Bouard, L., Weklak, D., Hamdan, F., Chan, C. K., Jönsson, F., Chabot, E., Musielak, C., Scurti, E., Feola, S., Schellhorn, S., Beaude, N., Schröer, K., Sarkar, D., Koukou, G., Wang, X., Schmidt, N. & Bayer, W. & 12 andra, , 2026, I: iScience. 29, 1Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review
-
Assessment of a Semi-solid Extrusion Based Compounding System Solution for Personalized Ondansetron Dosage Forms Combined with Raman Spectroscopy Analysis
Bahman, M., Zini, J., Lahtinen, J., Hassinen, N., Verma, S., Laaksonen, T., Airaksinen, S., Topelius, N. S. & Viitala, T., sep. 2025, I: Pharmaceutical Research. 42, 9, s. 1631-1645 15 s.Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review
Öppen tillgångFil -
Cell-based surface plasmon resonance approach for monitoring the inhibitory effect of Evasin-3 on Interleukin-8
Zhao, Y., Hadavi, D., Scurti, E., Viitala, T., Dijkgraaf, I. & Honing, M., 15 juli 2025, I: Analytica Chimica Acta. 1359, 6 s., 344091.Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review
Öppen tillgångFil -
Functional enzyme delivery via surface-modified mesoporous silica nanoparticles in 3D printed nanocomposite hydrogels
Mahran, A., Howaili, F., Bhadane, R., Mathiyalagan, R., Viitala, T., Wang, X. & Rosenholm, J. M., 1 aug. 2025, I: European Journal of Pharmaceutical Sciences. 211, 107132.Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review
Öppen tillgångFil3 Citeringar (Scopus)14 Nedladdningar (Pure)
Aktiviteter
- 4 Värd för en akademisk besökare
-
Usama Jamshaid
Rosenholm, J. (Värd) & Viitala, T. (Värd)
1 sep. 2024 → 6 dec. 2024Aktivitet: Stå värd för en besökare › Värd för en akademisk besökare
-
Metin Yildirim
Viitala, T. (Värd)
2 juli 2024 → 27 sep. 2024Aktivitet: Stå värd för en besökare › Värd för en akademisk besökare
-
Maxim Bril’kov
Viitala, T. (Värd)
17 apr. 2023 → 17 maj 2023Aktivitet: Stå värd för en besökare › Värd för en akademisk besökare
-
Aryane Vigato
Rosenholm, J. (Värd) & Viitala, T. (Värd)
1 sep. 2022 → 31 mars 2023Aktivitet: Stå värd för en besökare › Värd för en akademisk besökare